comparemela.com
Home
Live Updates
Post-hoc Analysis Offers Hope for Novel Cholesterol Drug : comparemela.com
Post-hoc Analysis Offers Hope for Novel Cholesterol Drug
Vupanorsen disappointed on triglyceride and non-HDL cholesterol reduction in TRANSLATE-TIMI 70, but post-hoc data on VLDL and remnant cholesterol point to a role for the class if not the drug, experts say.
Related Keywords
Milan ,
Lombardia ,
Italy ,
Herlev ,
Hovedstaden ,
Denmark ,
Copenhagen ,
Køavn ,
Massachusetts ,
United States ,
Boston ,
Gentofte ,
Nicholasa Marston ,
,
Pfizer ,
Marston ,
European Atherosclerosis Society Congress On ,
Medscape Cardiology ,
European Atherosclerosis Society Congress ,
Gentofte Hospital ,
Lipids ,
Ipid Management ,
Triglycerides ,
Hyperlipidemia ,
Atherosclerosis ,
Cv ,
Ardiovascular ,
Low Ldl Cholesterol ,
Ypobetalipoproteinemia ,
Ow Low Density Lipoprotein Cholesterol ,
Lipoproteins ,
Myocardial Infarction ,
High Density Lipoprotein Cholesterol ,
Fdl C ,
Dl ,
Dyslipidemia ,
comparemela.com © 2020. All Rights Reserved.